NYSE:ITGR

Integer (ITGR) Stock Price, News & Analysis

$111.25
-12.02 (-9.75%)
(As of 04/25/2024 ET)
Today's Range
$110.00
$120.00
50-Day Range
$98.56
$123.34
52-Week Range
$69.40
$123.99
Volume
1.61 million shs
Average Volume
422,347 shs
Market Capitalization
$3.73 billion
P/E Ratio
41.36
Dividend Yield
N/A
Price Target
$120.50

Integer MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
8.3% Upside
$120.50 Price Target
Short Interest
Bearish
7.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.18mentions of Integer in the last 14 days
Based on 28 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
15.63%
From $5.31 to $6.14 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.19 out of 5 stars

Medical Sector

764th out of 908 stocks

Electromedical Equipment Industry

14th out of 18 stocks

ITGR stock logo

About Integer Stock (NYSE:ITGR)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

ITGR Stock Price History

ITGR Stock News Headlines

Integer (NYSE:ITGR) Sets New 52-Week High at $121.63
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Q1 2024 Integer Holdings Corp Earnings Call
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Integer (ITGR) Scheduled to Post Earnings on Thursday
Integer (NYSE:ITGR) Reaches New 12-Month High at $119.51
Integer (NYSE:ITGR) Upgraded to Buy by Bank of America
The Latest Analyst Ratings For Integer Holdings
KeyBanc Keeps Their Buy Rating on Integer Holdings (ITGR)
See More Headlines
Receive ITGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
4/25/2024
Next Earnings (Confirmed)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Previous Symbol
NASDAQ:ITGR
CUSIP
39153L10
Employees
10,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$120.50
High Stock Price Target
$139.00
Low Stock Price Target
$88.00
Potential Upside/Downside
+8.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$90.65 million
Pretax Margin
6.72%

Debt

Sales & Book Value

Annual Sales
$1.60 billion
Cash Flow
$7.49 per share
Book Value
$45.58 per share

Miscellaneous

Free Float
32,834,000
Market Cap
$3.73 billion
Optionable
Optionable
Beta
1.10
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Joseph W. DziedzicMr. Joseph W. Dziedzic (Age 56)
    President, CEO & Director
    Comp: $3.24M
  • Mr. Diron Smith (Age 50)
    Executive VP & CFO
    Comp: $651.22k
  • Mr. McAlister C. Marshall II (Age 54)
    Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary
    Comp: $854.89k
  • Mr. Kirk K. Thor (Age 60)
    Executive VP & Chief Human Resources Officer
    Comp: $791.64k
  • Mr. Payman Khales (Age 54)
    President of Cardio & Vascular
    Comp: $1.14M
  • Mr. John Harris (Age 64)
    Executive Vice President of Global Operations & Manufacturing Strategy
    Comp: $521.18k
  • Mr. Tom P. Thomas (Age 53)
    VP, Corporate Controller & Principal Accounting Officer
  • Mr. Andrew Senn (Age 42)
    Senior Vice President of Strategy, Business Development & Investor Relations
  • Ms. Margaret Carthy (Age 60)
    Executive VP of Global Quality & Regulatory Affairs
  • Mr. Jim Stephens (Age 50)
    President of Cardiac Rhythm Management & Neuromodulation

ITGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Integer stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ITGR shares.
View ITGR analyst ratings
or view top-rated stocks.

What is Integer's stock price target for 2024?

6 brokers have issued 1-year price objectives for Integer's stock. Their ITGR share price targets range from $88.00 to $139.00. On average, they predict the company's stock price to reach $120.50 in the next twelve months. This suggests a possible upside of 8.3% from the stock's current price.
View analysts price targets for ITGR
or view top-rated stocks among Wall Street analysts.

How have ITGR shares performed in 2024?

Integer's stock was trading at $99.08 at the start of the year. Since then, ITGR shares have increased by 12.3% and is now trading at $111.25.
View the best growth stocks for 2024 here
.

Are investors shorting Integer?

Integer saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,570,000 shares, an increase of 5.8% from the March 31st total of 2,430,000 shares. Based on an average daily trading volume, of 342,100 shares, the short-interest ratio is presently 7.5 days. Approximately 7.8% of the shares of the stock are sold short.
View Integer's Short Interest
.

How were Integer's earnings last quarter?

Integer Holdings Co. (NYSE:ITGR) issued its quarterly earnings results on Thursday, February, 15th. The medical equipment provider reported $1.39 EPS for the quarter, beating the consensus estimate of $1.34 by $0.05. The medical equipment provider earned $413.15 million during the quarter, compared to analyst estimates of $409.04 million. Integer had a trailing twelve-month return on equity of 10.80% and a net margin of 5.68%. The business's quarterly revenue was up 10.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.11 earnings per share.

What guidance has Integer issued on next quarter's earnings?

Integer updated its FY 2024 earnings guidance on Thursday, April, 25th. The company provided earnings per share (EPS) guidance of 5.010-5.430 for the period, compared to the consensus EPS estimate of 5.310. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.

What is Joseph Dziedzic's approval rating as Integer's CEO?

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Who are Integer's major shareholders?

Integer's stock is owned by a number of retail and institutional investors. Top institutional investors include Congress Asset Management Co. MA (1.36%), Tributary Capital Management LLC (0.85%), Allspring Global Investments Holdings LLC (0.66%), Congress Wealth Management LLC DE (0.21%), New York State Teachers Retirement System (0.15%) and Raymond James & Associates (0.15%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Donald J Spence, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends
.

How do I buy shares of Integer?

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ITGR) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners